94 related articles for article (PubMed ID: 1295322)
21. Demonstration of a sucrose-derived contrast agent for magnetic resonance imaging of the GI tract.
Martinez GV; Navath S; Sewda K; Rao V; Foroutan P; Alleti R; Moberg VE; Ahad AM; Coppola D; Lloyd MC; Gillies RJ; Morse DL; Mash EA
Bioorg Med Chem Lett; 2013 Apr; 23(7):2061-4. PubMed ID: 23481651
[TBL] [Abstract][Full Text] [Related]
22. Curcumin/Gd loaded apoferritin: a novel "theranostic" agent to prevent hepatocellular damage in toxic induced acute hepatitis.
Cutrin JC; Crich SG; Burghelea D; Dastrù W; Aime S
Mol Pharm; 2013 May; 10(5):2079-85. PubMed ID: 23548053
[TBL] [Abstract][Full Text] [Related]
23. Quantitative rapid steady state T1 magnetic resonance imaging for cerebral blood volume mapping in mice: Lengthened measurement time window with intraperitoneal Gd-DOTA injection.
Perles-Barbacaru AT; Berger F; Lahrech H
Magn Reson Med; 2013 May; 69(5):1451-6. PubMed ID: 22760854
[TBL] [Abstract][Full Text] [Related]
24. An intravascular MRI contrast agent based on Gd(DO3A-Lys) for tumor angiography.
Yang CT; Chandrasekharan P; He T; Poh Z; Raju A; Chuang KH; Robins EG
Biomaterials; 2014 Jan; 35(1):327-36. PubMed ID: 24138829
[TBL] [Abstract][Full Text] [Related]
25. [Artificial contrasting during magnetic resonance tomography].
Sergeev PV; Panov OV; Egorova SV; Bolotova EN; Shimanovskii NL; Akhadov TA; Sviridov NK
Vestn Rentgenol Radiol; 1997; (1):45-52. PubMed ID: 9133071
[No Abstract] [Full Text] [Related]
26. Contrast-enhanced magnetic resonance angiography: P792 blood pool agent versus Gd-DOTA in rabbits at 3.0 T versus 1.5 T.
Herborn CU; Watkins DM; Baumann S; Robert P; Corot C; Runge VM
Invest Radiol; 2007 Sep; 42(9):622-8. PubMed ID: 17700277
[TBL] [Abstract][Full Text] [Related]
27. Magnetic resonance colonography with fecal tagging: an innovative approach without bowel cleansing.
Lauenstein TC; Debatin JF
Top Magn Reson Imaging; 2002 Dec; 13(6):435-44. PubMed ID: 12478023
[TBL] [Abstract][Full Text] [Related]
28. Differential passage of gadolinium through the mouse inner ear barriers evaluated with 4.7T MRI.
Zou J; Zhang W; Poe D; Zhang Y; Ramadan UA; Pyykkö I
Hear Res; 2010 Jan; 259(1-2):36-43. PubMed ID: 19818391
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and cellular uptake of a MR contrast agent coupled to an antisense peptide nucleic acid--cell- penetrating peptide conjugate.
Su W; Mishra R; Pfeuffer J; Wiesmüller KH; Ugurbil K; Engelmann J
Contrast Media Mol Imaging; 2007; 2(1):42-9. PubMed ID: 17318918
[TBL] [Abstract][Full Text] [Related]
30. The CAM cancer xenograft as a model for initial evaluation of MR labelled compounds.
Zuo Z; Syrovets T; Wu Y; Hafner S; Vernikouskaya I; Liu W; Ma G; Weil T; Simmet T; Rasche V
Sci Rep; 2017 May; 7():46690. PubMed ID: 28466861
[TBL] [Abstract][Full Text] [Related]
31. Convection-enhanced delivery of liposomes to primate brain.
Krauze MT; Forsayeth J; Yin D; Bankiewicz KS
Methods Enzymol; 2009; 465():349-62. PubMed ID: 19913176
[TBL] [Abstract][Full Text] [Related]
32. First in vivo MRI study on theranostic dendrimersomes.
Filippi M; Catanzaro V; Patrucco D; Botta M; Tei L; Terreno E
J Control Release; 2017 Feb; 248():45-52. PubMed ID: 28069551
[TBL] [Abstract][Full Text] [Related]
33. Frequency-shift based detection of BMS contrast agents using SSFP: potential for MRA.
Dubois J; Lethimonnier F; Vaufrey F; Robert P; Le Bihan D
Magn Reson Imaging; 2005 Apr; 23(3):453-62. PubMed ID: 15862646
[TBL] [Abstract][Full Text] [Related]
34. Size-dependent passage of liposome nanocarriers with preserved posttransport integrity across the middle-inner ear barriers in rats.
Zou J; Sood R; Ranjan S; Poe D; Ramadan UA; Pyykkö I; Kinnunen PK
Otol Neurotol; 2012 Jun; 33(4):666-73. PubMed ID: 22569149
[TBL] [Abstract][Full Text] [Related]
35. [MRI of acute myocardial infarction with injection of Gd-DOTA (15 patients)].
Richoz B; Delcour C; Depelchin P; Lenaers A; Jacquemin C; Gusella P; Struyven J
Ann Radiol (Paris); 1990; 33(2):93-8. PubMed ID: 2221784
[TBL] [Abstract][Full Text] [Related]
36. First in vivo MRI assessment of a self-assembled metallostar compound endowed with a remarkable high field relaxivity.
Livramento JB; Weidensteiner C; Prata MI; Allegrini PR; Geraldes CF; Helm L; Kneuer R; Merbach AE; Santos AC; Schmidt P; Tóth E
Contrast Media Mol Imaging; 2006; 1(1):30-9. PubMed ID: 17193598
[TBL] [Abstract][Full Text] [Related]
37. Using the neurotransmitter serotonin to target imaging agents to glioblastoma cells.
Sturzu A; Sheikh S; Klose U; Echner H; Kalbacher H; Deeg M; Nägele T; Horger M; Ernemann U; Heckl S
Invest New Drugs; 2012 Dec; 30(6):2141-7. PubMed ID: 22212740
[TBL] [Abstract][Full Text] [Related]
38. Three-dimensional multiphase time-resolved low-dose contrast-enhanced magnetic resonance angiography using TWIST on a 32-channel coil at 3 T: a quantitative and qualitative comparison of a conventional gadolinium chelate with a high-relaxivity agent.
Giesel FL; Runge V; Kirchin M; Mehndiratta A; Gerigk L; Corell B; von Gall C; Kauczor HU; Essig M
J Comput Assist Tomogr; 2010; 34(5):678-83. PubMed ID: 20861769
[TBL] [Abstract][Full Text] [Related]
39. In vivo magnetic resonance imaging of mice liver tumors using a new gadolinium-based contrast agent.
Chen SH; Kuo YT; Cheng TL; Chen CY; Chiu YY; Lai JJ; Chang CC; Jaw TS; Wang YM; Liu GC
Kaohsiung J Med Sci; 2013 May; 29(5):246-53. PubMed ID: 23639510
[TBL] [Abstract][Full Text] [Related]
40. A new biodegradable and biocompatible gadolinium (III) -polymer for liver magnetic resonance imaging contrast agent.
Xiao Y; Xue R; You T; Li X; Pei F
Magn Reson Imaging; 2015 Jul; 33(6):822-8. PubMed ID: 25839395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
